Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Clinical Pharmacology and Therapeutics
|
June 19, 1998
Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes
H Takahashi, T Kashima, Y Nomizo, et al.
Pharmacogenetics
|
November 24, 1998
Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes
H Takahashi, T Kashima, S Nomoto, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
January 3, 2013
Acute kidney injury after myeloablative cord blood transplantation in adults: the efficacy of strict monitoring of vancomycin serum trough concentrations
H Mae, J Ooi, S Takahashi, et al.
Clinical Pharmacology and Therapeutics
|
December 29, 1999
Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone
H Takahashi, T Sato, Y Shimoyama, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
September 1, 1999
Active oxygen species generation and cellular damage by additives of parenteral preparations: selenium and sulfhydryl compounds
A Terada, M Yoshida, Y Seko, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1994
Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes
E Koyama, D R Sohn, S G Shin, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
February 9, 2010
A novel microsatellite polymorphism of sodium channel beta1-subunit gene (SCN1B) may underlie abnormal cardiac excitation manifested by coved-type ST-elevation compatible with Brugada syndrome in Japanese
R Ogawa, R Kishi, A Takagi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 25, 1999
Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance
H Takahashi, T Kashima, S Kimura, et al.
Journal of Clinical Pharmacy and Therapeutics
|
January 11, 2014
Longitudinal monitoring of CYP3A activity in patients receiving 3 cycles of itraconazole pulse therapy for onychomycosis
S Shibata, H Takahashi, N Ono, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
March 27, 2001
[No relation between angiotensin-converting enzyme (ACE) inhibitor-induced cough and ACE gene polymorphism, plasma bradykinin, substance P and ACE inhibitor concentration in Japanese patients]
H Okumura, E Nishimura, S Kariya, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Clinical Pharmacology and Therapeutics
|
June 19, 1998
Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes
H Takahashi, T Kashima, Y Nomizo, et al.
Pharmacogenetics
|
November 24, 1998
Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes
H Takahashi, T Kashima, S Nomoto, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
January 3, 2013
Acute kidney injury after myeloablative cord blood transplantation in adults: the efficacy of strict monitoring of vancomycin serum trough concentrations
H Mae, J Ooi, S Takahashi, et al.
Clinical Pharmacology and Therapeutics
|
December 29, 1999
Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone
H Takahashi, T Sato, Y Shimoyama, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
September 1, 1999
Active oxygen species generation and cellular damage by additives of parenteral preparations: selenium and sulfhydryl compounds
A Terada, M Yoshida, Y Seko, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1994
Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes
E Koyama, D R Sohn, S G Shin, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
February 9, 2010
A novel microsatellite polymorphism of sodium channel beta1-subunit gene (SCN1B) may underlie abnormal cardiac excitation manifested by coved-type ST-elevation compatible with Brugada syndrome in Japanese
R Ogawa, R Kishi, A Takagi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 25, 1999
Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance
H Takahashi, T Kashima, S Kimura, et al.
Journal of Clinical Pharmacy and Therapeutics
|
January 11, 2014
Longitudinal monitoring of CYP3A activity in patients receiving 3 cycles of itraconazole pulse therapy for onychomycosis
S Shibata, H Takahashi, N Ono, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
March 27, 2001
[No relation between angiotensin-converting enzyme (ACE) inhibitor-induced cough and ACE gene polymorphism, plasma bradykinin, substance P and ACE inhibitor concentration in Japanese patients]
H Okumura, E Nishimura, S Kariya, et al.
Page
of 8